Top Banner
Taking Innovation to Market Dummy copy March 2014
16
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Swati Spentose Private Limited, Mumbai

Taking Innovation to Market

Dummy copyMarch 2014

Page 2: Swati Spentose Private Limited, Mumbai

Group

V

GROUP

Manufacturing Facility (FDA compliant)

2005

In-house R&D Lab1999

Exports and Distribution company

1970

CHIRAL CHEMICALSSpecialty Fine Chemicals

and Nutraceuticals2000

ALCON BIOSCIENCESGMP Certified Company

1998

Page 3: Swati Spentose Private Limited, Mumbai

1952 - Group established under the name Euresian Chemicals &

equipment in Kolkata (trading in steel, chemicals &

pharmaceuticals)

1970 - Late chairman Mr. Narayan Jajodia, arrived into Mumbai

to specialize in the business of API

1970 - Distribution business within India & in over 30 countries

- Extra ordinary skills and networks globally in sourcing new

molecules

- Representing some of the best Pharmaceutical

manufacturers in Europe

1996 - Logical backward integration into manufacturing of bulk

drugs having a strong market position

History

Page 4: Swati Spentose Private Limited, Mumbai

40 years of Business Experience

Clients in 60 countries

An Iconic Niche manufacturing platform

Polysaccharide Specialists – Niche Science

Global opportunities for 2 niche molecule in our pipeline

Today & Tomorrow

Page 5: Swati Spentose Private Limited, Mumbai

SSPL Unit I

Ultra-filtration

Block

Multi-purpose

block

Pilot Plant

SSPL Unit II

Steroids

SSPL Unit III

Premixes

SSPL Unit IV

Hormones

SSPL Unit V

Xylan & Nutra-

ceuticals

SSPL Unit VI

Dextran

SSPL Unit VII

Formulation

Infrastructure Strength – Multiple Sites

Page 6: Swati Spentose Private Limited, Mumbai

SSPL Flagship Site at Vapi, Gujarat

Page 7: Swati Spentose Private Limited, Mumbai

New Facility complying latest global cGMP & ICH guidelines as per

all international regulatory agencies such as UK-MHRA, USFDA,

EDQM, TGA -Australia, MCC-South Africa

Today In the complete pharmaceutical chain, Bulk Drug

manufacturing has become the most critical and weakest link in the

chain, India is the best country option ahead of China when it comes

to reliability & consistency in quality

The site is housed in a 6,000 m² area (64,560 ft²) with 3,978 m2

(42,800 ft²) manufacturing & storage area

Our Flagship Site – Unit 1

Page 8: Swati Spentose Private Limited, Mumbai

Unique characterization skills using

complex platforms like

Capillary Zone Electrophoresis from

Beckman Coulter, USA

Iconic Manufacturing Plant

using Ultra-filtration from

Sartorius Stedim, Germany

9 years of multi-dimensional specialization in PPS

Page 9: Swati Spentose Private Limited, Mumbai

Key API

API

Lidocaine

Meloxicam

Pentosan

Dextran

Hydroxy Ethyl Starch

Phenytoin

STEROIDS

Dutasteride

Fluocinolone

Halobetasol

Mometasone

Triamcinolone

NICHE MOLECULES

Iron Dextran

Granisetron

Iron Sucrose

Melatonin

Page 10: Swati Spentose Private Limited, Mumbai

Interstitial Cystitis Effort By SSPL

We have launched PPS, an effective and affordable

treatment for IC by the name of Comfora

(Reference: www.comfora.in)

It is the only FDA-approved oral medication for

bladder pain and discomfort

Comparative preclinical studies of SSPL’s pentosan

with the originator molecule at the Mount Sinai

School of Medicine, New York which have confirmed

that they have equivalent activity

Top class clinicians with 20 years of experience on

treating IC under IVAX, the originator are our

advisory board

Page 11: Swati Spentose Private Limited, Mumbai

SSPL’s Urology Range - Brands

• Dutride0.5mg dutasteride soft gelatin capsules

• Fin-Flow5mg finasteride tablet

• Terod1mg/2mg tolterodine tablet

• Tamysin0.2mg/0.4 mg tamsulosin tablet

• Dutride-T0.4mg tamsulosin + 0.5mg dutasteride capsules

Page 12: Swati Spentose Private Limited, Mumbai

Lean & efficient operations - Reduce high cost of funds

One of its kind business model, integrated platform

APIs are critical bottle neck in the pharmaceutical regulatedmarkets due to very stringent and complex FDA &

Environmental regulations.

Due to China not enjoying the best credibility, due to theirperpetual contamination controversies, we being slightlyexpensive are premium, as credibility, trust & human life ispriceless

Our Positioning

Page 13: Swati Spentose Private Limited, Mumbai

16 years of business experience, selling inover 60 countries on open credit withoutlosing a penny

Manufacturing & Research experience ofover 12 years, specially in handling people

Served on the board of several exportcouncils under the Ministry of Commerce,Government of India for more than 14 years,now as invited board member

Lead successfully industry policy mattersand problems with the Government

Introduction of our Chairman

Page 14: Swati Spentose Private Limited, Mumbai

Qualifications

Page 15: Swati Spentose Private Limited, Mumbai

Mr. Vishal Jajodia has been on the boards of the following councils at

various positions for last 16 years including Vice Chairman, under The

Ministry of Commerce, Govt. of India, also active in policy formation

aspects :

Chemexcil – Chemical Export Promotion Council

Pharmexcil – Pharmaceuticals Export Promotion Council

IDMA – Indian Drug Manufacturers Association

FIEO - Federation of India Exporters Organization

Export Councils

Page 16: Swati Spentose Private Limited, Mumbai

114,Marine Chambers,11, New Marine Lines,Mumbai- 400 020, India.

Phone: +91 22 66332437Fax: +91 22 2207 1955Site: www.spentose.com